Delphinus Medical Technologies is commercializing an ultrasound-based, diagnostic imaging system for the early detection of breast cancer.
delphinusmt.com
Novi, MI
CEO: Mark Forchette
Arboretum Lead: Paul McCreadie
Delphinus Medical Technologies
IN THE NEWS
Delphinus Raises $30 Million in Series D Funding to Transform Dense Breast Screening
Delphinus Medical Technologies, Inc. today announced the closing of a $30 million Series D financing to fuel worldwide commercialization of its SoftVue™ 3D Whole Breast Ultrasound Tomography System (SoftVue™). The round drew…
Read More
Karmanos Cancer Institute first to receive innovative, FDA-approved SoftVue™ Breast Imaging System
The Barbara Ann Karmanos Cancer Institute, the world-renowned, Detroit-based National Cancer Institute-Designated Comprehensive Cancer Center, is the first to receive the SoftVue™ 3D Whole Breast Ultrasound Tomography System (SoftVue™), following its approval by the…
Read More
